Targeted therapy, immunotherapy, and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.216633 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2024. Verfasst von Jingwen Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology and Translational Research, Department of Pathology, School of Biomedical Sciences, Faculty of Medicine and Health, University of Ne…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Peptidomimetics. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of New South Wales.
Abstract (Originalsprache)
Primary cutaneous melanoma is the most lethal of all skin neoplasms and its incidence is increasing. Clinical management of advanced melanoma in the last decade has been revolutionised by the availability of immunotherapies and targeted therapies, used alone and in combination. This article summarizes advances in the treatment of late-stage melanoma including use of protein kinase inhibitors, antibody-based immune checkpoint inhibitors, adoptive immunotherapy, vaccines and more recently, small molecules and peptidomimetics as emerging immunoregulatory agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vascular Biology and Translational Research, Department of Pathology, School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
- Kinghorn Cancer Centre, St Vincent's Hospital, Garvan Institute of Medical Research, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
- Department of Otorhinolaryngology, Head & Neck Surgery, ANU Medical School and Canberra Health Services, Australian National University, Acton, Canberra, ACT, Australia.
- Department of Pharmacology, School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
- Vascular Biology and Translational Research, Department of Pathology, School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia. Electronic address: L.Khachigian@uns…
Förderung
- University of New South Wales
Zitieren
APA
Zhang, J., Joshua, A. M., Li, Y., O'Meara, C. H., Morris, M. J., & Khachigian, L. M. (2024). Targeted therapy, immunotherapy, and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216633
Vancouver
Zhang J, Joshua AM, Li Y, O'Meara CH, Morris MJ, Khachigian LM. Targeted therapy, immunotherapy, and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216633
BibTeX
@article{Zhang2024,
author = {Zhang, Jingwen and Joshua, Anthony M and Li, Yue and O'Meara, Connor H and Morris, Margaret J and Khachigian, Levon M},
title = {Targeted therapy, immunotherapy, and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.216633}
}
EUVIMED